Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Monday.

GRDN has been the subject of a number of other research reports. Truist Financial lifted their price objective on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “sell (d+)” rating to a “hold (c)” rating in a report on Tuesday, November 11th. Finally, Oppenheimer assumed coverage on shares of Guardian Pharmacy Services in a research report on Friday, October 10th. They issued an “outperform” rating and a $30.00 price objective for the company. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Guardian Pharmacy Services currently has an average rating of “Moderate Buy” and a consensus target price of $30.67.

Guardian Pharmacy Services Stock Down 1.4%

NYSE:GRDN opened at $27.93 on Monday. Guardian Pharmacy Services has a 52-week low of $17.78 and a 52-week high of $37.43. The stock has a fifty day simple moving average of $27.02 and a 200-day simple moving average of $24.14. The company has a market capitalization of $1.77 billion, a PE ratio of 44.33 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Monday, November 10th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The business had revenue of $377.43 million for the quarter, compared to analyst estimates of $381.16 million. Guardian Pharmacy Services has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Guardian Pharmacy Services will post 0.87 earnings per share for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds have recently made changes to their positions in GRDN. State of Alaska Department of Revenue purchased a new stake in shares of Guardian Pharmacy Services during the 3rd quarter valued at $30,000. Parkside Financial Bank & Trust acquired a new position in Guardian Pharmacy Services in the second quarter valued at $41,000. Ameritas Investment Partners Inc. grew its position in Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after acquiring an additional 345 shares during the period. Raymond James Financial Inc. purchased a new stake in Guardian Pharmacy Services during the second quarter valued at about $43,000. Finally, Police & Firemen s Retirement System of New Jersey grew its position in Guardian Pharmacy Services by 76.8% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after acquiring an additional 1,062 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.